Genetically Engineered Bacterial Protein Nanoparticles for Targeted Cancer Therapy

Haiyan Yang,1 Fujie Jiang,1 Xiaojuan Ji,2 Lu Wang,1 Yaotai Wang,1 Liang Zhang,3 Yu Tang,1 Disen Wang,1 Yong Luo,1 Ningshan Li,1 Qi Wang,1 Jianzhong Zou1 1State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing 400016,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yang H, Jiang F, Ji X, Wang L, Wang Y, Zhang L, Tang Y, Wang D, Luo Y, Li N, Wang Q, Zou J
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/78d92f3cfc2c43ffb33e094370feb8ae
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:78d92f3cfc2c43ffb33e094370feb8ae
record_format dspace
spelling oai:doaj.org-article:78d92f3cfc2c43ffb33e094370feb8ae2021-12-02T14:24:01ZGenetically Engineered Bacterial Protein Nanoparticles for Targeted Cancer Therapy1178-2013https://doaj.org/article/78d92f3cfc2c43ffb33e094370feb8ae2021-01-01T00:00:00Zhttps://www.dovepress.com/genetically-engineered-bacterial-protein-nanoparticles-for-targeted-ca-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Haiyan Yang,1 Fujie Jiang,1 Xiaojuan Ji,2 Lu Wang,1 Yaotai Wang,1 Liang Zhang,3 Yu Tang,1 Disen Wang,1 Yong Luo,1 Ningshan Li,1 Qi Wang,1 Jianzhong Zou1 1State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing 400016, China; Chongqing Key Laboratory of Biomedical Engineering, Chongqing Medical University, Chongqing 400016, People’s Republic of China; 2Department of Ultrasound, Children’s Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders; National Clinical and Research Center of Child Health and Disorders; China International Science and Technology Cooperation Base of Child Development and Critical Disorders; Chongqing Engineering Research Center of Stem Cell Therapy, Chongqing 400016, People’s Republic of China; 3Institute of Ultrasound Imaging, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, People’s Republic of ChinaCorrespondence: Jianzhong ZouState Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, Yuzhong District 400016, People’s Republic of ChinaTel +86-13708302390Email zoujzh@cqmu.edu.cnPurpose: Cancer treatment still faces big challenges in the clinic, which is raising concerns over the world. In this study, we report the novel strategy of combing bacteriotherapy with high-intensity focused ultrasound (HIFU) therapy for more efficient breast cancer treatment.Methods: The acoustic reporter gene (ARG) was genetically engineered to be expressed successfully in Escherichia coli (E. coli) to produce the protein nanoparticles-gas vesicles (GVs). Ultrasound was utilized to visualize the GVs in E. coli. In addition, it was injected intravenously for targeted breast cancer therapy by combing the bacteriotherapy with HIFU therapy.Results: ARG expressed in E. coli can be visualized in vitro and in vivo by ultrasound. After intravenous injection, E. coli containing GVs could specifically target the tumor site, colonize consecutively in the tumor microenvironment, and it could obviously inhibit tumor growth. Meanwhile, E. coli which contained GVs could synergize HIFU therapy efficiently both in vitro and in vivo as the cavitation nuclei. Furthermore, the tumor inhibition rate in the combination therapy group could be high up to 87% compared with that in the control group.Conclusion: Our novel strategy of combing bacteriotherapy with HIFU therapy can treat breast cancers more effectively than the monotherapies, so it can be seen as a promising strategy.Keywords: acoustic reporter gene, gas vesicles, targeted cancer therapy, bacteriotherapy, high-intensity focused ultrasoundYang HJiang FJi XWang LWang YZhang LTang YWang DLuo YLi NWang QZou JDove Medical Pressarticleacoustic reporter genegas vesiclestargeted cancer therapybacteriotherapyhigh-intensity focused ultrasoundMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 16, Pp 105-117 (2021)
institution DOAJ
collection DOAJ
language EN
topic acoustic reporter gene
gas vesicles
targeted cancer therapy
bacteriotherapy
high-intensity focused ultrasound
Medicine (General)
R5-920
spellingShingle acoustic reporter gene
gas vesicles
targeted cancer therapy
bacteriotherapy
high-intensity focused ultrasound
Medicine (General)
R5-920
Yang H
Jiang F
Ji X
Wang L
Wang Y
Zhang L
Tang Y
Wang D
Luo Y
Li N
Wang Q
Zou J
Genetically Engineered Bacterial Protein Nanoparticles for Targeted Cancer Therapy
description Haiyan Yang,1 Fujie Jiang,1 Xiaojuan Ji,2 Lu Wang,1 Yaotai Wang,1 Liang Zhang,3 Yu Tang,1 Disen Wang,1 Yong Luo,1 Ningshan Li,1 Qi Wang,1 Jianzhong Zou1 1State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing 400016, China; Chongqing Key Laboratory of Biomedical Engineering, Chongqing Medical University, Chongqing 400016, People’s Republic of China; 2Department of Ultrasound, Children’s Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders; National Clinical and Research Center of Child Health and Disorders; China International Science and Technology Cooperation Base of Child Development and Critical Disorders; Chongqing Engineering Research Center of Stem Cell Therapy, Chongqing 400016, People’s Republic of China; 3Institute of Ultrasound Imaging, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, People’s Republic of ChinaCorrespondence: Jianzhong ZouState Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, Yuzhong District 400016, People’s Republic of ChinaTel +86-13708302390Email zoujzh@cqmu.edu.cnPurpose: Cancer treatment still faces big challenges in the clinic, which is raising concerns over the world. In this study, we report the novel strategy of combing bacteriotherapy with high-intensity focused ultrasound (HIFU) therapy for more efficient breast cancer treatment.Methods: The acoustic reporter gene (ARG) was genetically engineered to be expressed successfully in Escherichia coli (E. coli) to produce the protein nanoparticles-gas vesicles (GVs). Ultrasound was utilized to visualize the GVs in E. coli. In addition, it was injected intravenously for targeted breast cancer therapy by combing the bacteriotherapy with HIFU therapy.Results: ARG expressed in E. coli can be visualized in vitro and in vivo by ultrasound. After intravenous injection, E. coli containing GVs could specifically target the tumor site, colonize consecutively in the tumor microenvironment, and it could obviously inhibit tumor growth. Meanwhile, E. coli which contained GVs could synergize HIFU therapy efficiently both in vitro and in vivo as the cavitation nuclei. Furthermore, the tumor inhibition rate in the combination therapy group could be high up to 87% compared with that in the control group.Conclusion: Our novel strategy of combing bacteriotherapy with HIFU therapy can treat breast cancers more effectively than the monotherapies, so it can be seen as a promising strategy.Keywords: acoustic reporter gene, gas vesicles, targeted cancer therapy, bacteriotherapy, high-intensity focused ultrasound
format article
author Yang H
Jiang F
Ji X
Wang L
Wang Y
Zhang L
Tang Y
Wang D
Luo Y
Li N
Wang Q
Zou J
author_facet Yang H
Jiang F
Ji X
Wang L
Wang Y
Zhang L
Tang Y
Wang D
Luo Y
Li N
Wang Q
Zou J
author_sort Yang H
title Genetically Engineered Bacterial Protein Nanoparticles for Targeted Cancer Therapy
title_short Genetically Engineered Bacterial Protein Nanoparticles for Targeted Cancer Therapy
title_full Genetically Engineered Bacterial Protein Nanoparticles for Targeted Cancer Therapy
title_fullStr Genetically Engineered Bacterial Protein Nanoparticles for Targeted Cancer Therapy
title_full_unstemmed Genetically Engineered Bacterial Protein Nanoparticles for Targeted Cancer Therapy
title_sort genetically engineered bacterial protein nanoparticles for targeted cancer therapy
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/78d92f3cfc2c43ffb33e094370feb8ae
work_keys_str_mv AT yangh geneticallyengineeredbacterialproteinnanoparticlesfortargetedcancertherapy
AT jiangf geneticallyengineeredbacterialproteinnanoparticlesfortargetedcancertherapy
AT jix geneticallyengineeredbacterialproteinnanoparticlesfortargetedcancertherapy
AT wangl geneticallyengineeredbacterialproteinnanoparticlesfortargetedcancertherapy
AT wangy geneticallyengineeredbacterialproteinnanoparticlesfortargetedcancertherapy
AT zhangl geneticallyengineeredbacterialproteinnanoparticlesfortargetedcancertherapy
AT tangy geneticallyengineeredbacterialproteinnanoparticlesfortargetedcancertherapy
AT wangd geneticallyengineeredbacterialproteinnanoparticlesfortargetedcancertherapy
AT luoy geneticallyengineeredbacterialproteinnanoparticlesfortargetedcancertherapy
AT lin geneticallyengineeredbacterialproteinnanoparticlesfortargetedcancertherapy
AT wangq geneticallyengineeredbacterialproteinnanoparticlesfortargetedcancertherapy
AT zouj geneticallyengineeredbacterialproteinnanoparticlesfortargetedcancertherapy
_version_ 1718391434089857024